Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
Status:
Not yet recruiting
Trial end date:
2027-12-30
Target enrollment:
Participant gender:
Summary
To evaluate if adjuvant concurrent chemoradiotherapy is associated with a recurrence-free
survival benefit in comparison with radiotherapy alone in selected intermediate risk cervical
cancer after radical surgery.